Lipocine appoints ex-J&J executive Michael Grissinger to board

• Lipocine appointed Michael J. Grissinger to its board, effective Aug. 3, 2026.
• Grissinger spent more than two decades at Johnson & Johnson, including VP roles leading worldwide pharmaceutical licensing and corporate development, M&A.
• He previously worked 12 years at Ciba-Geigy in finance, marketing, business development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608030800PR_NEWS_USPR_____LA17257) on August 03, 2026, and is solely responsible for the information contained therein.